Direct access to content
The May 30, 2011
New England Biolabs (NEB), a world leader in the production and supply of reagents for the life science industry, extends its global subsidiary network with the opening of New England Biolabs France, located at Bioparc Genopole in Evry.
Jim Ellard, President and CEO of NEB Inc, was on hand to officially open the new subsidiary and remarked Bioparc Genopole is the perfect location for NEB France. It is a superb research campus where high-level research in genomics and post-genomics has been conducted since 1998. It has attracted biotech companies like New England Biolabs to provide personalized advice and support to research scientists in the Paris area. We expect to have a mutually beneficial relationship with the researchers here, helping them to advance science.
France is a very important part of the European life science community and the opening of NEB France brings more direct and efficient access to NEB's high quality reagents and industry-leading technical support and service to French researchers.
Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications, and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and subsidiaries located in Canada, China, France, Germany, Japan and the UK. For more information about New England Biolabs, visit www.neb.com.
update April 19, 2012